Search
Dave Martin assists real estate companies, real estate investment trusts (REITs) and other businesses in complex acquisitions and dispositions of office, retail, industrial and multi-family properties, including multi-million dollar portfolios and joint venture arrangements, across the United States...
Andrew Schwerin represents clients in patent and trade secret litigation on both the plaintiff and defense sides of these disputes. Outside of his litigation work, Andrew counsels clients on their IP strategy. Andrew has represented clients in connection with a range of technologies including...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
Igor Pleskov advises clients on real estate transactions, including the acquisition, disposition, financing and leasing of property. He represents major institutions, owners of building portfolios, developers, REITs, lenders and end-users across the United States, including several clients in...
Erik Williams assists clients with commercial real estate transactions, with an emphasis on site acquisition, disposition, finance, construction, and leasing matters. He has advised a broad range of public and private clients, from small entrepreneurs to large institutions. Erik also represents...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Bruce Smiley draws on more than 45 years of experience counseling international and national companies as well as local Southern California businesses and families regarding the legal aspects of transactional real estate matters. Bruce's practice encompasses both public and private sector...
Kevin M. Levy focuses primarily on real estate matters, including property sales and acquisitions, leases, commercial real estate lending and borrowing, development projects and real estate tax appeals. Kevin also advised clients on COVID-19 regulatory compliance and has commented extensively on...
Brian Michalek helps companies protect their technological innovations, advances and brand reputation through his intellectual property law practice. As a patent litigator, he has advised clients on a variety of disputes involving software-based technologies, wireless transactions and communications...
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...
Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...
Tony Forte concentrates his practice in the area of commercial real estate development and transactions, with an emphasis on site acquisition, land use approvals and permitting, construction, historic preservation, and leasing matters. Most recently, Tony has provided real estate legal counsel to...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...
Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...
Brandon Brauer's practice focuses primarily on commercial real estate transactions, including leases, purchases and sales, financings, construction contracts and condominium regime work. Brandon's experience includes single-asset and portfolio transactions with respect to multifamily properties...